Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy - 03/11/23
, R. Max Segnitz, PhD b, ∗, David Larson, PhD c, Naresh Doni Jayavelu, PhD a, Malisa T. Smith, MS b, Sana Patel, MD b, Guy W. Scadding, MD d, Tielin Qin, PhD c, Srinath Sanda, MD e, Esther Steveling, MD d, Aarif O. Eifan, MD d, Martin Penagos, MD, MSc d, Mikila R. Jacobson d, Rebecca V. Parkin, BSc d, Mohamed H. Shamji, PhD d, Alkis Togias, MD f, ‡, Stephen R. Durham, MD dAbstract |
Background |
Allergen immunotherapy (AIT) is a well-established disease-modifying therapy for allergic rhinitis, yet the fundamental mechanisms underlying its clinical effect remain inadequately understood. Gauging Response in Allergic Rhinitis to Sublingual and Subcutaneous Immunotherapy was a randomized, double-blind, placebo-controlled trial of individuals allergic to timothy grass who received 2 years of placebo (n = 30), subcutaneous immunotherapy (SCIT) (n = 27), or sublingual immunotherapy (SLIT) (n = 27) and were then followed for 1 additional year.
Objective |
We used yearly biospecimens from the Gauging Response in Allergic Rhinitis to Sublingual and Subcutaneous Immunotherapy study to identify molecular mechanisms of response.
Methods |
We used longitudinal transcriptomic profiling of nasal brush and PBMC samples after allergen provocation to uncover airway and systemic expression pathways mediating responsiveness to AIT. Trial Registration: ClinicalTrials.gov Identifier: NCT01335139, EudraCT Number: 2010-023536-16.
Results |
SCIT and SLIT demonstrated similar changes in gene module expression over time. In nasal samples, alterations included downregulation of pathways of mucus hypersecretion, leukocyte migration/activation, and endoplasmic reticulum stress (log2 fold changes −0.133 to −0.640, false discovery rates [FDRs] <0.05). We observed upregulation of modules related to epithelial development, junction formation, and lipid metabolism (log2 fold changes 0.104 to 0.393, FDRs <0.05). In PBMCs, modules related to cellular stress response and type 2 cytokine signaling were reduced by immunotherapy (log2 fold changes −0.611 to −0.828, FDRs <0.05). Expression of these modules was also significantly associated with both Total Nasal Symptom Score and peak nasal inspiratory flow, indicating important links between treatment, module expression, and allergen response.
Conclusions |
Our results identify specific molecular responses of the nasal airway impacting barrier function, leukocyte migration activation, and mucus secretion that are affected by both SCIT and SLIT, offering potential targets to guide novel strategies for AIT.
Le texte complet de cet article est disponible en PDF.Key words : Allergen immunotherapy, sublingual immunotherapy, subcutaneous immunotherapy, RNA sequencing, allergic rhinitis
Abbreviations used : AIT, AR, AUC, ER, FDR, GRASS, NAC, PNIF, SCIT, SLIT, TGP, TNSS
Plan
Vol 152 - N° 5
P. 1247-1260 - novembre 2023 Retour au numéro
Article précédent
- Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics
- Ali Al-Janabi, Paul Martin, Adnan R. Khan, Amy C. Foulkes, Catherine H. Smith, Christopher E.M. Griffiths, Andrew P. Morris, Steve Eyre, Richard B. Warren, BSTOP Study Group and the BADBIR Study Group, Shehnaz Ahmed, Oras Alabas, Jonathan Barker, Gabrielle Becher, Anthony Bewley, Ian Evans, Philip Hampton, Brian Kirby, Elise Kleyn, Philip Laws, Linda Lawson, Teena Mackenzie, Kathleen McElhone, Tess McPherson, Simon Morrison, Caroline Owen, Eleanor Pearson, Amir Rashid, Nick Reynolds, Anja Strangfeld, Shernaz Walton, Zenas Yiu, Girish Gupta, Anja Strangfeld (chair), Richard Weller, Vera Zietemann, Nadia Aldoori, Mahmud Ali, Ahmed Al-Rusan, Caroline Angit, Alex Anstey, Fiona Antony, Charles Archer, Suzanna August, Periasamy Balasubramaniam, David Baudry, Kay Baxter, Anthony Bewley, Alexandra Bonsall, Sara Brown, Victoria Brown, David Burden, Ekaterina Burova, Aamir Butt, Mel Caswell, Anna Chapman, Sandeep Cliff, Mihaela Costache, Sharmela Darne, Claudia DeGiovanni, Trupti Desai, Victoria Diba, Eva Domanne, Michael Duckworth, Harvey Dymond, Caoimhe Fahy, Susanne Farwer, Leila Ferguson, Maria-Angeliki Gkini, Alison Godwin, Jon Goulding, Fiona Hammonds, Shaheen Haque, Caroline Higgins, Sue Hood, Teresa Joseph, Sarah Johnson, Manju Kalavala, Mohsen Khorshid, Liberta Labinoti, Ruth Lamb, Nicole Lawson, Alison Layton, Tara Lees, Nick Levell, Helen Lewis, Chris Lovell, Calum Lyon, Helen McAteer, Sandy McBride, Sally McCormack, Kevin McKenna, Serap Mellor, Fiona Meredith, Ruth Murphy, Paul Norris, Caroline Owen, Richard Parslew, Gay Perera, Nabil Ponnambath, Urvi Popli, James Powell, Raakhee Ramesh, Helen Ramsay, Aruni Ranasinghe, Saskia Reeken, Nick Reynolds, Rebecca Rose, Rada Rotarescu, Ingrid Salvary, Kathy Sands, Tapati Sinha, Julia Schofield, Alexa Shipman, Stefan Siebert, Simina Stefanescu, Kavitha Sundararaj, Kathy Taghipour, Michelle Taylor, Michelle Thomson, Joanne Topliffe, Roberto Verdolini, Rachel Wachsmuth, Martin Wade, Shymal Wahie, Sarah Walsh, Shernaz Walton, Louise Wilcox, Diane Williamson, Andrew Wright
- RelB-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent
- Héctor I. Navarro, Yi Liu, Anna Fraser, Diane Lefaudeux, Jennifer J. Chia, Linda Vong, Chaim M. Roifman, Alexander Hoffmann
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?